Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Vijay Kuchroo
Brigham and Women's Hospital, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Celsius Therapeutics
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
The project investigates the molecular mechanisms by which the cytokine IL-23 regulates the balance between pathogenic and nonpathogenic Th17 cells. The company has licensed the cytokine.
T cell response to myelin proteolipid protein
This project deals with studying the molecular mechanisms that make Th17 cells pathogenic and induce autoimmune disease of the central nervous system called Experimental Autoimmune Encephalomyelitis (EAE). Using transcriptomic analysis we have identified a kinase called SGK-1 which promotes pathogenic Th17 response while another molecule CD5l promotes generation of nonpathogenic Th17 cells. Using a number of novel 'knock-down' tools, we are studying the mechanism by which IL-23 regulates balance between pathogenic and nonpathogenic Th17 cells by affecting SGK-1 vs. CD5l.
Filed on September 24, 2018.
Tell us what you know about Vijay Kuchroo's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Vijay Kuchroo filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Vijay Kuchroo | Brigham and Women's Hospital | Conflict of Interest | Celsius Therapeutics | $0 - $4,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.